Obinutuzumab for the First-Line Treatment of Follicular Lymphoma.
N Engl J Med. 2017 Oct 5;377(14):1331-1344. doi: 10.1056/NEJMoa1614598.
N Engl J Med. 2017.
PMID: 28976863
Free article.
Clinical Trial.